Amneal

Quote
JR has been way to quite…they are going to sell the Specialty division and focus on generics and biosimilars. Been down that road before. That is why all the top people are leaving. They know what is coming.

Most people in management is looking as well..watch the trends..look at the financials..not good long term.
 




anonymous said:
JR has been way to quite…they are going to sell the Specialty division and focus on generics and biosimilars. Been down that road before. That is why all the top people are leaving. They know what is coming.

Most people in management is looking as well..watch the trends..look at the financials..not good long term.
Click to expand...
While I’m not sure you are wrong I don’t see how this plays out. What assets of value does Amneal Specialty have to offer? We just bought a product that failed at another company. Not exactly a hot asset. We have Rytary that goes generic in a year. That has no resale value. Next is IPX. That has a less than certain future and even if it does hit how valuable is that to another company? That leaves Unithroid. I have no experience with that and have no idea its value. At least it’s making money so that has some value. So walk me through what is going to sell? It makes more financial sense to play the string out of what we have OR just cut bait
 




anonymous said:
JR has been way to quite…they are going to sell the Specialty division and focus on generics and biosimilars. Been down that road before. That is why all the top people are leaving. They know what is coming.

Most people in management is looking as well..watch the trends..look at the financials..not good long term.
Click to expand...
 








In my opinion they will cut the entire sales force.If they ever get approval for IPX I believe they will hire a contract company for less money. It appears to be all about the . Always follow the money.
 




anonymous said:
In my opinion they will cut the entire sales force.If they ever get approval for IPX I believe they will hire a contract company for less money. It appears to be all about the . Always follow the money.
Click to expand...

you hit the nail on the head. The word on the street is they are going to fill PD openings with Contract reps. Hedging their bets on the IPX and the uptake of Ong. Biosimilars is the future of this company. They are keeping the lights on. Although have we ever met any of those reps? It’s like they keep them at arms length from the rest of us. Unfortunately for us we are going to be compared to the Endo team with upper management trying to replicate their ‘success’ on the PD side.
 




anonymous said:
JR has been way to quite…they are going to sell the Specialty division and focus on generics and biosimilars. Been down that road before. That is why all the top people are leaving. They know what is coming.

Most people in management is looking as well..watch the trends..look at the financials..not good long term.
Click to expand...

This is hard to figure out. Running down the list of ‘leaders’ we’ve had since I’ve been here there’s some improvement but not a lot. Gustavo was the absolute worst but Nestor was a close second. I’m not sure what JT actually did but his counterpart from Endo is someone everyone spoke highly about. JR seems to at least have a plan and some energy but is disconnected from the Sales Force unless you are in his special group.
The big question - is HK better than SH? Thats a tough call. HK got rid of some folks that needed getting rid. And a few who didn’t. SH at least had a heart for the front line sales folks that is sorely lacking at this point. They both were incredible micromanagers but HK takes the title there. They both played favorites and it seems like a tie there. Fortunately I was never on either bad side
It’s awesome having everyone back on PD but we are still separated from Endo while still being compared with Endo. .
To me what is absolutely telling is that the attrition rate under JR/HK appears to have only accelerated not slowed down. Sales reps are still dropping at an alarming rate and there appears no plan to correct that. To me that’s alarming. To them it appears as part of the plan.
 




Why would they move PD reps. to Endo? Are employees being let go after evals? If contract reps. for PD then why not Endo? We lost 2 strong sales reps. in TX in the last 2 weeks. Shouldn’t this be a wake up call to JR and HK that the direction of company has put everyone in a concerned state of mind?
 








anonymous said:
Why would they move PD reps. to Endo? Are employees being let go after evals? If contract reps. for PD then why not Endo? We lost 2 strong sales reps. in TX in the last 2 weeks. Shouldn’t this be a wake up call to JR and HK that the direction of company has put everyone in a concerned state of mind?
Click to expand...

They moved 4 or 5 from Spasticity to Endo when the dissolved that team. I think all of them had Rytary experience. Then they just hired a slew of new Endo reps. The writing appears to be on the wall for PD. Our days are numbered. We are going to become both a Biosimilar company on one end and an entry level PCP company on the other. I’m going to hold out to NSM to see what is being said and NOT being said not from stage but at the bar
 




anonymous said:
I do not think they care!They change the focus of this company every time the wind blows.
Click to expand...

They absolutely don’t care. HK hasn’t been in charge of a Sales team for longer than 2 years. She’s a short timer here. JR brought her in as a favor. Just like our new PD leader is here because of a favor from HK. Biosimilars is pretty much left alone but the have their own issues. But they are making money hand over fist so they will be free to do what they want. FA is the only hold over from the previous regime but Endo is the Golden child so his massive turnover won’t raise an eyebrow.
 




Talk was loose at the bar and rumor has it that FA goes ballistic when a rep leaves even if it’s for $20 K more. He believes the culture here should stop turnover. The culture starts at his level.
 








FA’s culture is one of fear and intimidation. That’s why everyone is leaving. He is upset because he cannot control them when they leave. Each rep that leaves is more proof he’s not in control.
 




The above poster is so right. He punishes those that do not fall in line. Why do you think we are told to change the way we’ve been doing things? Hang out at the bar at NSM.
 








anonymous said:
He does not know how to manage and should be let go!
Click to expand...

He is one of HKs favorites. He’s not going anywhere. Now a true sales leader, which we know HK is not, would take a look at the incredible amount of turnover he’s had and have a lot of questions. At some point it’s not the fault of the reps who are leaving. At some point it’s Gotta be leadership. And if it’s not FA then it’s His RBMS. When was the last RBM dismissed? Will he ever be held accountable? Neither GP nor SO had this much turnover. Yet they were unceremoniously dumped. How much money does it cost in lost field time, recruiting and trading costs for the revolving door that is Endo. I know I’ll be missing 10 or so of my friends from PD at NSM. Endo has to probably have 50% new people.
 




They need the turnover, so they can replace us with contract reps. It’s how the company started and it’s how it will end. Everybody knows what is coming, it’s just if we want to accept it. If the new PD drug was that good, we wouldn’t even be considering OGT. It’s a short term play due to money concerns.
 




anonymous said:
They need the turnover, so they can replace us with contract reps. It’s how the company started and it’s how it will end. Everybody knows what is coming, it’s just if we want to accept it. If the new PD drug was that good, we wouldn’t even be considering OGT. It’s a short term play due to money concerns.
Click to expand...

They are only replacing PD reps. with contractors. Endo reps. do not earn the same salaries so they are safe. Many leave for more pay, but that’s expected. Endo is delivering profits which is good for everyone.
 




anonymous said:
They are only replacing PD reps. with contractors. Endo reps. do not earn the same salaries so they are safe. Many leave for more pay, but that’s expected. Endo is delivering profits which is good for everyone.
Click to expand...

Absolutely ! Biosims and Endo are keeping the lights on. Which is both good and bad We have tried to be known as a PD company. It’s almost like Endo and Biosims are two seperate entities supporting PD. I have maybe met my Biosims counterpart 1 time. Endo is easy to find. They will be at the bar drunk every night at NSM ha
 




Top Bottom
Back
Quote